Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Chamberlin loss narrows; Corero inks Latam deal

Wed, 21st Feb 2024 14:33

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Angling Direct PLC - Norfolk, England-based fishing tackle retailer - Expects annual revenue of GBP81.7 million for the year ended January 31, up 10% from GBP74.1 million the year before. This was driven by a 9.0% increase in UK sales to GBP77.4 million from GBP71.0 million the year before, and a 7.6% rise in retail store sales to GBP44.4 million from GBP41.3 million. Online sales jumped 14% to GBP37.2 million from GBP32.8 million. Chief Executive Officer Steve Crowe says: "Angling Direct has continued to gain market share in the UK and Europe, and we believe there are significant further growth opportunities in both markets. The group will continue to invest in its digital and physical footprint in the UK to capture further market share growth, leveraging its strong balance sheet to ensure it is competitively placed as consumer confidence returns. Since the period end, the UK business has completed one small footprint store acquisition in Crewe and opened one new store in Cannock, alongside committing substantial capital investment to an automated customer order packaging solution for the UK distribution centre."

----------

Rights & Issues Investment Trust PLC - Essex, England-based investor in smaller UK companies - Net asset value per share at December 31 2,337.1 pence, up 2.4% from 2,283.2p a year ago. NAV total return for 2023 was 2.4%, compared to negative 25% at the end of 2022. This is slightly lower than the FTSE All-Share index benchmark return of 3.8%. Recommends a final dividend of 31.25p per share, up from 29.25p a year prior. Total dividend is 43p, up 7.5% from 40p.

----------

Clean Power Hydrogen PLC - Doncaster, England-based green hydrogen technology and manufacturing company - Successfully completes its functional test of the programme logic control of the MFE110 system for Northern Ireland Water. The programme logic control represents the coded programme which automatically operates the MFE110 including shutdown, it says. Says the successful test was witnessed by Lagan MEICA Ltd, the contractor to Northern Ireland Water, and means the factory acceptance test can progress to the final stages. CEO Jon Duffy comments: "The successful test of the programme logic control allowing for fully automated operation, signifies an important part of the MFE110's journey to commercial production of hydrogen and medical grade oxygen. While the pausing of the FAT test in November 2023 due to issues regarding the shutdown mechanism were disappointing, I am extremely proud of the team for re-evaluating the important safety shut down measures, and successfully finding a solution which has put us back on track to completing the MFE110 for our customers in the very near-term future."

----------

Chamberlin PLC - West Midlands-based specialist castings and engineering group - Says performance for the half year ended November 30 was broadly in line with expectations. Interim pretax loss narrows to GBP78,000 from GBP467,000 a year ago. Revenue grows 1.0% to GBP10.6 million from GBP10.5 million a year prior. Looking ahead, says prospects for sustainable growth are achievable over the short to medium term. It is also moving forward with improved working capital resources in regard to its steel output. Separately, Chamberlin announces the sale of Petrel Ltd to Project Apollo Ltd for a total cash consideration of GBP3 million.

----------

Cambridge Cognition Holdings PLC - Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health - Inks deal with ActiGraph for digital measurements of central nervous system trials. Chief scientist at Cambridge Cognition Francesca Cormack says: "CNS disorders are characterised by a host of heterogeneous symptoms which impact daily life, but that are often inadequately addressed by existing treatments. Our partnership with ActiGraph represents an exciting combination of expertise in objective digital measures of actigraphy, speech and cognition that will help accelerate the development of treatments for patients and improve efficiency in clinical trials."

----------

Corero Network Security PLC - London-based cybersecurity provider - Creates strategic Latin American partnership with Brazilian networks solutions distribution, TechEnabler. CEO Carl Herberger says: "Creating this strategic partnership with TechEnabler provides an ideal platform to expand our product reach in a key growth market for Corero, alongside aligning our business with a partner who shares our commitment to cybersecurity excellence. This agreement reinforces our focus on security innovation, which in turn will allow a new crop of businesses to fortify their networks against DDoS attacks whilst exploring further opportunities to leverage our cutting-edge solutions."

----------

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
29 Sep 2014 11:54

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
24 Sep 2014 08:58

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
11 Sep 2014 10:21

Cambridge Cognition Narrows Pretax Loss In First-Half

Read more
13 Aug 2014 09:28

Cambridge Cognition Expands Partnership With Altreos Research

Read more
2 Jul 2014 08:50

Cambridge Cognition To Meet Full-Year Expectations As Half Year Ahead

Read more
26 Jun 2014 09:50

Cambridge Cognition Confident For Full-Year On Contract Wins

Read more
5 Jun 2014 09:34

Cambridge Cognition Holdings Signs Contracts For Cognitive Safety Trial

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that it has signed a contract for a global multi-year study in which its Cantab Solutions technology will be used to assess the cognitive safety of a new medicine under development for cardiovascular disease. The contra

Read more
3 Jun 2014 08:12

Cambridge Cognition Launches First iPad Product For Clinical Trials

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Tuesday that it had launched the first of its two iPad-based products on its Cantab Connect digital platform for use in clinical trials. Its product, called The Clinical Trials Information System Adverse Effects, allows for the

Read more
28 May 2014 10:08

Cambridge Cognition rolls out new health app in Lincolnshire

Computerised neuropsychological test specialists Cambridge Cognition announced its Cantab Mobile app has been released by North East Lincolnshire Clinical Commissioning Group into the medical sector. The group's app will be introduced to five GP surgeries, five pharmacies and Grimbsy hospital to he

Read more
28 May 2014 10:00

Cambridge Cognition Mobile App Rolled Out In North East Lincolnshire

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that the North East Lincolnshire Clinical Commissioning Group has introduced its Cantab mobile app in five GP surgeries, five pharmacies and Grimsby hospital to help diagnose dementia earlier. The firm, which specialis

Read more
8 May 2014 11:58

Cambridge Cognition Reiterates Confidence On Return To Growth

LONDON (Alliance News) - Cambridge Cognition Holdings PLC Thursday reiterated confidence that it would be able to return to growth in 2014, in a statement ahead of its annual general meeting. The biotechnology company said that it had seen a positive start to trading in the first quarter of

Read more
2 Apr 2014 10:29

Cambridge Cognition Appoints Non-Executive Chairman

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday it has appointed Michael Lewis as non-executive Chairman. The company, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, said Lewis will take over from

Read more
13 Mar 2014 12:08

Cambridge Cognition Confident For Return To Growth In 2014

LONDON (Alliance News) - Cambridge Cognition Holdings PLC expressed confidence Thursday that it would return to growth in 2014, after it posted a widened pretax loss in 2013 due to lower revenue. Cambridge Cognition provides computerised neuropsychological tests, particularly to enable earl

Read more
3 Mar 2014 11:00

Cambridge Cognition Launches Latest Research Software

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Monday it has launched the Cantab Research Suite, the latest offering in its cognitive testing platform for academic research. Cambridge, which specialises in computerised neuropsychological tests, such as those enabling the ear

Read more
26 Nov 2013 14:14

Cambridge Cognition Holdings Says Pharmaceutical Arm Struggling, Remains Confident Looking Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.